Bank of America’s Immunogen Inc IMGN Stock Holding History

Bank of America’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$284K	–	8806
2021 Q3	$284K	Hold	50,000	–	–	﹤0.01%	6046
2021 Q2	$330K	Buy	+50,000	New	+$349K	﹤0.01%	5734
2019 Q2	–	Sell	-50,000	Closed	-$136K	–	7488
2019 Q1	$136K	Buy	+50,000	New	+$217K	﹤0.01%	5715
2016 Q2	–	Sell	-60,000	Closed	-$511K	–	7460
2016 Q1	$511K	Buy	+60,000	New	+$508K	﹤0.01%	4588
2015 Q1	–	Sell	-12,100	Closed	-$74K	–	7678
2014 Q4	$74K	Buy	+12,100	New	+$111K	﹤0.01%	6102

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's IMGN Position: Q1 2024 in Review

Bank of America sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 780,279 shares — an estimated $23.1M sold.

Bank of America first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $23.1M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Bank of America reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Bank of America sold 780,279 Immunogen Inc shares in Q1 2024, an estimated $23.1M.
Bank of America first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
Bank of America's Immunogen Inc position peaked at $23.1M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.